
Pharmacies and shippers can be active participants from the loading dock to the front door by using available data and analytics to make better business decisions in successfully shipping their next patient medication.

Pharmacies and shippers can be active participants from the loading dock to the front door by using available data and analytics to make better business decisions in successfully shipping their next patient medication.

Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses what health systems can do to address the national blood shortage and increase blood donations.

Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains how palliative care can support the cancer treatment process, and how specialty pharmacies can support this type of care.

The company’s decision to take melphalan flufenamide off the market was made after dialogue and interactions with the FDA.

The new drug application submission of parsaclisib (Incyte) was based on data from several phase 2 studies that evaluate the treatment.

SER-109, an investigational, oral, biologically-sourced microbiome therapeutic designed to reduce recurrence of C. difficile infection (CDI), demonstrated a 31.1% absolute reduction in the rate of CDI recurrence over 12 weeks compared to placebo

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses common themes or key points being raised in the field of psychedelic medicine at recent conferences.

Endometriosis most commonly involves the ovaries, fallopian tubes, and the tissue lining the pelvis.

Boyd hopes to see the various study results on diet's role in conditions such as high blood pressure and chronic kidney disease to further help patients.

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Dr. Cary Boyd-Shiwarski explains how nonsteroidal mineralcorticoid receptor antagonists and novel potassium-binding agents alter the management of hyperkalemia and approaching potassium handling in chronic kidney disease.

Boyd gave a general overview of how potassium handling works in chronic kidney disease, specifically with hyperkalemia.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses some best clinical practices for psychedelic-assisted therapy in terms of assessing pharmacological profile.

Structural changes to the COVID-19 virus highlight the need to expand the research efforts.

Galindo hopes that less patients will be diagnosed with advanced chronic kidney disease if we use the right glucose-lowering agents in the earliest stages.

Galindo explained how the use of glucose-lowering agents in patients with diabetes and low eGFR improved patient care.

Galindo gave a general overview of his session and explained the new standards of care for chronic kidney disease which he has felt made a great impact on the field.

NETs can occur almost anywhere in the body, although they are most common in the gastrointestinal tract and lungs.

An ectopic pregnancy occurs when a fertilized egg implants and grows outside the main cavity of the uterus.

The FDA also granted Priority Review designation for the toripalimab BLA and set a Prescription Drug User Fee Act action date for April 2022; however, the FDA is not currently planning to hold an advisory committee meeting to discuss the application.

In addition to the prevention of disease in children, COVID-19 vaccination can also limit disruptions in school attendance so that children can participate safely in school and other activities.

The AHA emphasizes the importance of looking at a total dietary pattern, including amounts, balance, combinations, and variety of beverages and food consumer regularly.

Agency's interpretation may significantly affect how health systems and hospitals provide pharmaceuticals to patients.

Mei Ka Fong, PharmD, BCOP, said there are multiple treatment approaches for patients with NETs.

The study also collected patient-reported outcomes in routine clinical practice to understand the impact of treatment on health-related quality of life.

TNBC is the most aggressive and lethal form of the disease.

Pharmacists and technicians have an opportunity to prove their value as immunizers now that the Pfizer-BioNTech COVID-19 vaccine has been authorized for use in children ages 5 to 11.

Cystic fibrosis affects the cells that produce mucus, sweat, and digestive juices.

Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.

The results also showed they were nearly 20 times more effective at preventing hospitalizations from the virus for individuals older than 65 than a prior infection alone.